Evgeny Nikolsky Appointed as JTI Romania, Moldova, Bulgaria GM

News by 2FIRSTS.ai

Feb.22.2024

Evgeny Nikolsky Appointed as JTI Romania, Moldova, Bulgaria GM

Evgeny Nikolsky appointed as new general manager of JTI in Romania, Moldova, and Bulgaria, following successful career progression.

Recently, according to a statement released by Japan Tobacco International (JTI), Evgeny Nikolsky has been appointed as the new General Manager of JTI in Romania, Moldova, and Bulgaria.

Nikolsky joined JTI in 2001 and has since advanced his career and professional skills in brand and trade marketing. In 2009, he became the country sales director. In 2014, he managed city distributors in Russia before becoming the sales director for JTI Russia. In 2016, he returned to Kazakhstan and since 2018, he has also been coordinating JTI's activities in Central Asia and Mongolia.

Niculescu expressed his excitement for the appointment, stating, "I am pleased to have the opportunity to live and work in Romania. JTI has been operating in this country for 30 years, holding over 28% market share and introducing the e-cigarette product Logic Compact in recent years.

Former CEO Mark Rock will continue to lead JTI Germany.

References:

[1] Evgeny Nikolsky is the new General Manager of JTI Romania

Also Read:

[1] VPR Brands Appoints TPB Canada as Exclusive Distributor for HoneyStick

[2] Wade Huckabee Appointed Senior Vice President of BAT's Subsidiary

[3] Dr. Moira Gilchrist Promoted as PMI's Chief Communication Officer

[4] Kaival Brands Appoints James W. Dobbins as General Counsel

[5] Navaneel Kar Appointed as Director General of IPM India

#Europe #E-cigarettes #Romania #JTI #Bulgaria #Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

BAT accused of “utter hypocrisy” over efforts to dilute Zambia’s tobacco bill

The Guardian reports that British American Tobacco urged Zambian ministers to drop or delay ad and sponsorship bans and to soften a draft tobacco bill by shrinking health warnings, easing flavour restrictions and lowering penalties. Critics said the stance is hypocritical given similar rules apply in the UK.

Nov.13

BAT plans to sell its stake in ITC Hotels, using proceeds to reduce debt

British American Tobacco (BAT) plans to sell all or part of its stake in ITC Hotels via an accelerated bookbuild, with the sale size expected to be up to 15.3% of the company’s shares. The company says the proceeds will be used to reduce debt and bring its leverage back within the target range.

Dec.05 by 2FIRSTS.ai

2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock

2Firsts observed on FOGER’s online retail site “FOGER VAPES” that the platform indicates restocking delays due to customs and tariff factors. Several items show limited availability or “sold out” status, with a restock alert feature offered. A previous article on the site also referenced potential tariff changes that may affect pricing.